Non-small cell lung cancer (stage III)

Clinical trials for Non-small cell lung cancer (stage III) explained in plain language.

Never miss a new study

Get alerted when new Non-small cell lung cancer (stage III) trials appear

Sign up with your email to follow new studies for Non-small cell lung cancer (stage III), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 8 Not yet recruiting 2 Not yet finished but already full! 5 Completed 1 Terminated 2

Can an immune booster make standard lung cancer treatment more effective?

Disease control Completed

This trial is investigating whether adding the immunotherapy drug nivolumab to the usual chemotherapy and radiation can improve outcomes for people with stage III non-small cell lung cancer. The study will measure how well the combination works and how tolerable the side effects …

Matched conditions: NON-SMALL CELL LUNG CANCER (STAGE III)

Phase 2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control

Last updated Aug 26, 2026 00:00 UTC

Non-small cell lung cancer (stage III)

Get alerted when new Non-small cell lung cancer (stage III) trials appear

Can an immune booster make standard lung cancer treatment more effective?